Feasibility of CALM in Patients With Ovarian Cancer
Key facts
- Where
- Toronto, KanadaSee the site
Where in Kanada
- Princess Margaret Cancer CentreToronto, KanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Health Network, Toronto
- Trial code
- NCT06459271
- Record updated
- 2026. augusztus 24.
- Original description
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC).Read full original descriptionShow less
A Feasibility Trial of Managing Cancer and Living Meaningfully (CALM) in Patients With Newly Diagnosed and Recurrent Advanced Ovarian Cancer
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC).
The main questions are:
1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What is the patient experience of CALM-TF at new diagnosis or recurrence
Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.
Inclusion: new diagnosis or recurrence of stage III or stage IV OC; age ≥18 years; able to complete outcome measures and engage in CALM in English.
Exclusion: receiving psychological or psychiatric counseling from the Department of Supportive Care at PM at the time of recruitment; evidence of cognitive impairment indicated in the medical record, communicated by the OC clinic team, or determined by research staff at recruitment.